Authored by: Katrina Adlerz, PhD, Scientist, RoosterBio and Divya Patel, PhD, Scientist, RoosterBio MSC-EVs Emerge as a Cell-Free Therapy Extracellular vesicle (EV) interest continues to increase as more evidence emerges ... More
Originally Published: July 7, 2014 Updated October 2019 by: Taby Ahsan, Ph.D., Vice President of Analytical, Process & Product Development & Katrina Adlerz, Ph.D., Scientist, Development What is Population Doubling Level ... More
Authored by Iain Farrance, PhD, Technical Marketing Associate Introduction Human mesenchymal stromal cells (hMSC) are considered the “workhorse” of Regenerative Medicine (RegenMed). hMSC are a critical starting material in a growing variety of ... More
We’re thrilled to share that we’ve been named a Frederick County Best Places to Work! This award is especially meaningful to us because our company was built with culture in ... More
Authored by Katrina Adlerz, Ph.D., Scientist, Analytics, Product & Process Development & Josephine Lembong, Ph.D., Scientist, Analytics, Product & Process Development The 2019 International Society for Cell and Gene Therapy (ISCT) ... More
Authored by Mayasari Lim, Ph.D., Regional Account Manager, West Coast, RoosterBio Bioprinting overview The field of 3D bioprinting has exploded in recent years largely due to the advances in additive ... More
Authored by Josephine Lembong, Ph.D., Scientist, Product & Process Development & Jon Rowley, Ph.D., Founder and Chief Product Officer, RoosterBio Inc. Previously, we published a blog post on estimating hMSC ... More
Authored by Joseph Candiello, Ph.D., Technical Application Specialist Human Mesenchymal Stem/Stromal Cells (hMSCs) are a critical starting material in a growing variety of established and emerging applications spanning the Regenerative ... More
Authored by Josephine Lembong, Ph.D., Scientist, Product & Process Development & Jon A. Rowley, Ph.D., Founder and Chief Product Officer, RoosterBio Inc. Jon Rowley, RoosterBio’s Founder and Chief Product Officer, gave a talk at ... More
Authored by Katrina Adlerz, Ph.D. Scientist, Analytical Development, RoosterBio Inc. RoosterBio attended the International Society for Cell Therapy annual meeting, held May 2-5, 2018 in Montreal, which brought together leaders ... More